Financial Data and Key Metrics Changes - As of December 31, 2025, the loan portfolio principal totaled approximately $411 million across 26 portfolio companies, with a weighted average yield to maturity of 16.3%, down from 16.5% in the third quarter [11] - Net interest income for the fourth quarter was $14.2 million, a 4% increase from $13.7 million in the third quarter, primarily due to the collection of past due interest [17] - Distributable earnings per weighted average share were approximately $0.44 for the fourth quarter and $1.92 for the year, with a book value per common share of $14.60 as of December 31, 2025 [19][20] Business Line Data and Key Metrics Changes - Gross originations during the fourth quarter were approximately $19 million, with $5 million advanced to a new borrower and $14 million to existing borrowers [11] - The portfolio consisted of 37.6% fixed-rate loans and 62.4% floating-rate loans, with only 9% exposed to further rate declines [13][14] Market Data and Key Metrics Changes - The current pipeline stands at $616 million, indicating strong demand for growth capital within the cannabis sector [8] - Recent positive momentum in cannabis policy includes President Trump's executive order to reclassify cannabis from Schedule I to Schedule III, which could improve industry economics [9] Company Strategy and Development Direction - The company focuses on debt investments in the cannabis industry, leveraging limited competition to structure senior secured positions with differentiated downside risk [4][6] - The strategy emphasizes a disciplined focus on credit and collateral, with a strong emphasis on risk management and collaboration with borrowers [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to execute on the pipeline and achieve net portfolio growth despite liquidity constraints [24] - The company maintains a conservative approach to underwriting, not lowering standards despite increased demand for debt capital due to rescheduling [26][45] Other Important Information - The company has a CECL reserve of approximately $5.1 million, representing 1.23% of outstanding principal, maintaining strong real estate coverage of 1.2 times [18] - Total leverage was 32% of book equity as of December 31, 2025, with $49.1 million outstanding on the senior secured revolving credit facility [15][16] Q&A Session Summary Question: Outlook on pipeline and net portfolio growth - Management remains confident in achieving net portfolio growth, with $50 million of liquidity available for deployment [24] Question: Current yields and impact of rescheduling - Rescheduling has increased demand for debt capital but has not changed pricing or underwriting processes [26] Question: Competition in the market - No new lenders have entered the market post-rescheduling, and significant reforms are needed to increase competition [30][31] Question: Loan number nine's additional funding - The additional funding was part of a recapitalization strategy to improve the borrower's cash flow and operations [37][38] Question: Early repayments on loans - Loan number one was refinanced, while loan number 27 was paid off without pursuing refinancing due to various considerations [42] Question: Pipeline increase and pricing consistency - The increase in the pipeline reflects a broader range of opportunities, but underwriting standards and pricing remain unchanged [44][45]
Chicago Atlantic Real Estate Finance(REFI) - 2025 Q4 - Earnings Call Transcript